Statistics from Altmetric.com
Advances in multimodal cancer-directed treatment have improved survival for metastatic cancer patients. In the Western world the combination of various demographic, health-related and sociological factors will contribute to increased comorbidities and mortality over the next decade. A careful, evidence-based approach is necessary to address the inevitable challenges, which will be posed by an increasingly aged population that will require supportive care towards the end of their lives.1 Further investment in palliative care research is required to generate the evidence which will improve the care delivered to patients approaching death.2 Currently, funding for end-of-life and palliative care research is inadequate. Data on UK research funding by National Cancer Research Institute partners in …
Contributors All authors of this letter have directly participated in its drafting. All authors of this letter have read and approved the final version submitted.
Funding The ‘Friends of the University of Liverpool’ has provided funding, to the sum of £10,000, to cover equipment costs and running costs attributable to the study.
Competing interests None.
Ethics approval This study received a favorable ethical opinion from the North Wales Research Ethics Committee—West in 2012.
Provenance and peer review Not commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.